MAPK3 and pulmonary arterial hypertension: In human lung fibroblasts and vascular smooth muscle cells, ET-1 activates at least one mitogen-activated protein kinases (MAPK), ERK1/2, which in turn activates cyclins and cyclin-dependent kinases resulting in cell proliferation and subsequently PASMC hyperplasia in PAH [15,16].